Chance of reimbursement for ADD-ON therapies in Poland and in the world - review of the reimbursement recommendations
Przegl Epidemiol
; 72(1): 99-109, 2018.
Article
in En
| MEDLINE
| ID: mdl-29667385
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Reimbursement Mechanisms
/
Breast Neoplasms
/
Urogenital Neoplasms
/
Antineoplastic Agents, Immunological
/
Antibodies, Monoclonal
Type of study:
Guideline
/
Health_technology_assessment
/
Prognostic_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Przegl Epidemiol
Year:
2018
Document type:
Article